Search - tctmd.com

Displaying 41 - 60 of 62

Sort: Relevancy | Date

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

News Conference News EuroPCR 2018

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

Michael O'Riordan

May 23, 2018

News Conference News EuroPCR 2018

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

Yael L. Maxwell

May 22, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Conference News EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Michael O'Riordan

May 22, 2018

News Conference News EuroPCR 2018

Big Data, Big Questions: Physicians and Innovators Consider AI’s Role in Clinical Care

Michael O'Riordan

May 21, 2018

News Industry News

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

May 17, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Conference News SCAI 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Shelley Wood

May 04, 2018

News Industry News

Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy

May 01, 2018

News Industry News

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

April 09, 2018

News Conference News ACC 2018

NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients

Shelley Wood

March 10, 2018

News Conference News CRT 2018

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

Michael O'Riordan

March 08, 2018

News Daily News

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Todd Neale

February 21, 2018

News Daily News

Lotus Valve’s Return to Market in Europe Sees Further Delays

Shelley Wood

November 29, 2017

News Industry News

Boston Scientific Closes Symetis Acquisition

May 16, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

Video

» Conference Wrap-Up

EuroPCR 2018 Wrap-Up Interview: Yael L. Maxwell interviews Dr. Davide Capodanno at EuroPCR 2018

July 10, 2018

Advertisement

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Modest Benefit of PCI Over Medical Therapy in Patients With ‘Grey Zone’ FFR Lesions

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Big Data, Big Questions: Physicians and Innovators Consider AI’s Role in Clinical Care

ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients

Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Lotus Valve’s Return to Market in Europe Sees Further Delays

Boston Scientific Closes Symetis Acquisition

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

EuroPCR 2018 Wrap-Up Interview: Yael L. Maxwell interviews Dr. Davide Capodanno at EuroPCR 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content